Question

Is stem cell therapy for Spinal Cord Injury worth it?

Outside an authorised trial, evidence does not support paying for an unidentified cell or exosome product as established spinal-cord repair. Independent spinal-cord and rehabilitation specialists should compare the exact study with comprehensive established care.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Spinal Cord Injury

Spinal cord injury varies by neurological level, completeness, cause and time since injury. Research includes neural progenitors, oligodendrocyte-lineage products, MSCs, scaffolds and exosomes with different goals and risks. An injection near or into the spinal cord does not establish cell survival, circuit integration, restored walking or recovery of bladder and bowel function.

Am I a candidate? → · Spinal Cord Injury: full overview → · Spinal Cord Injury cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information